SPECTROBID Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Spectrobid, and when can generic versions of Spectrobid launch?
Spectrobid is a drug marketed by Pfizer and is included in two NDAs.
The generic ingredient in SPECTROBID is bacampicillin hydrochloride. There are two drug master file entries for this compound. Additional details are available on the bacampicillin hydrochloride profile page.
Summary for SPECTROBID
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 39 |
Patent Applications: | 778 |
DailyMed Link: | SPECTROBID at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for SPECTROBID
US Patents and Regulatory Information for SPECTROBID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | SPECTROBID | bacampicillin hydrochloride | FOR SUSPENSION;ORAL | 050556-001 | Mar 23, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | SPECTROBID | bacampicillin hydrochloride | TABLET;ORAL | 050520-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | SPECTROBID | bacampicillin hydrochloride | TABLET;ORAL | 050520-002 | Sep 12, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |